Abstract：
The relevance of type 1 diabetes during pregnancy stems from its impact on the health of mother and offspring and its increasing prevalence. Glycemic control during pregnancy is one of the main risk factors for adverse events. Besides, treatment becomes a major challenge not only due to the modifications in insulin requirements due to changes in hormones and cytokines but also to the stricter control targets. Given the recent appearance of new ultra-rapid and basal insulin analogues and the constant evolution of technology to treat people with diabetes, we review these aspects in relation to the treatment of women with type 1 diabetes during pregnancy.
摘要：
怀孕期间1型糖尿病的相关性源于其对母亲和后代健康的影响及其患病率的增加。妊娠期血糖控制是不良事件的主要危险因素之一。此外,由于激素和细胞因子的变化，胰岛素需求的改变，治疗成为一个主要挑战，而且更严格的控制目标。鉴于最近出现了新的超快和基础胰岛素类似物，以及治疗糖尿病患者的技术不断发展，我们回顾了与妊娠期1型糖尿病女性治疗相关的这些方面.
